 |
인쇄하기
취소
|
FCB-Pharmicell to cerebrate GMP facility in Germany
FCB-Pharmicell, a local biopharmaceutical company, said it will complete the construction of its GMP facility in Germany on November 27, this year, to develop a new drug for the treatment of stroke using stem cells.
The company said its preclinical studies for stroke is to be completed in February next year and subsequent clinical studies are expected to finalize in the middle of 2009.
FC...
The company said its preclinical studies for stroke is to be completed in February next year and subsequent clinical studies are expected to finalize in the middle of 2009.
FC...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.